These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24129826)

  • 41. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.
    van Geenen RC; ten Kate FJ; de Wit LT; van Gulik TM; Obertop H; Gouma DJ
    Surgery; 2001 Feb; 129(2):158-63. PubMed ID: 11174708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.
    Dudeja V; Greeno EW; Walker SP; Jensen EH
    HPB (Oxford); 2013 Sep; 15(9):661-7. PubMed ID: 23458352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
    Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
    Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
    Kleive D; Labori KJ; Line PD; Gladhaug IP; Verbeke CS
    HPB (Oxford); 2020 Jan; 22(1):50-57. PubMed ID: 31186199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
    Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
    J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
    Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
    Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.
    Fujii T; Nakao A; Yamada S; Suenaga M; Hattori M; Takami H; Inokawa Y; Kanda M; Sugimoto H; Nomoto S; Murotani K; Kodera Y
    Surgery; 2015 Apr; 157(4):708-15. PubMed ID: 25704426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
    Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
    J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
    Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
    Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma.
    Lapshyn H; Schulte T; Sondermann S; May K; Petrova E; Honselmann KC; Braun R; Zemskov S; Keck T; Wellner UF; Bausch D; Bolm L
    Pancreatology; 2021 Jan; 21(1):155-162. PubMed ID: 33309623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration.
    Malleo G; Maggino L; Marchegiani G; Feriani G; Esposito A; Landoni L; Casetti L; Paiella S; Baggio E; Lipari G; Capelli P; Scarpa A; Bassi C; Salvia R
    Pancreatology; 2017; 17(5):847-857. PubMed ID: 28843714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
    Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
    Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
    [No Abstract]   [Full Text] [Related]  

  • 54. Significance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer.
    Tewari M
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):572-578. PubMed ID: 27919845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.
    Prakash LR; Wang H; Zhao J; Nogueras-Gonzalez GM; Cloyd JM; Tzeng CD; Kim MP; Lee JE; Katz MHG
    J Gastrointest Surg; 2020 Feb; 24(2):368-379. PubMed ID: 30820801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?
    Kelly KJ; Winslow E; Kooby D; Lad NL; Parikh AA; Scoggins CR; Ahmad S; Martin RC; Maithel SK; Kim HJ; Merchant NB; Cho CS; Weber SM
    J Gastrointest Surg; 2013 Jul; 17(7):1209-17; discussion 1217. PubMed ID: 23620151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of radiologic location and extent of portal venous involvement on prognosis after resection for pancreatic adenocarcinoma.
    Hwang JW; Kim SC; Song KB; Yoon JH; Nam JS; Lee JH; Park KM; Lee YJ
    Pancreas; 2015 May; 44(4):665-71. PubMed ID: 25806602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.
    Javed AA; Wright MJ; Siddique A; Blair AB; Ding D; Burkhart RA; Makary M; Cameron JL; Narang A; Herman J; Zheng L; Laheru D; Weiss MJ; Wolfgang C; He J
    J Gastrointest Surg; 2019 Jan; 23(1):112-121. PubMed ID: 30242644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of computer tomography and endoscopic ultrasonography in assessing portal and superior mesenteric vessels invasion in cephalo-pancreatic adenocarcinoma.
    Bodea R; Seicean A; Vasile T; Calinici T; Ciuca I; Al Hajjar N; Iancu C; Iordache C
    Ann Ital Chir; 2017; 88():336-341. PubMed ID: 29051395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.